Bavarian Nordic Reports Better Than Expected Preliminary Financial Results for 2022
January 16, 2023 03:32 ET | Bavarian Nordic A/S
All-time high revenues and EBITDA profitability for 2022 COPENHAGEN, Denmark, January 16, 2023 – Bavarian Nordic A/S (OMX: BAVA) today reported preliminary, unaudited financial results for 2022,...
Bavarian Nordic offentliggør bedre end forventede, foreløbige resultater for 2022
January 16, 2023 03:32 ET | Bavarian Nordic A/S
Leverer rekordomsætning og EBITDA-overskud i 2022 KØBENHAVN, Danmark, 16. januar 2023 – Bavarian Nordic A/S (OMX: BAVA) rapporterede i dag foreløbige, ureviderede finansielle resultater for 2022, som...
Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine Encephalitis Virus Vaccine
December 23, 2022 02:05 ET | Bavarian Nordic A/S
Total considerations of up to USD 83 million with the majority secured for Phase 2 development of the multivalent MVA-BN® WEV vaccine candidate, in addition to options for Phase 3 preparatory work ...
Bavarian Nordic indgår aftale på op til USD 83 mio. med det amerikanske forsvar om videreudvikling af vaccine mod hesteencephalitvirus
December 23, 2022 02:05 ET | Bavarian Nordic A/S
Aftalen har en samlet værdi af op til USD 83 mio., hvoraf størstedelen er sikret til fase 2-udviklingen af den multivalente MVA-BN® WEV vaccinekandidat. Aftalen rummer desuden optioner på...
Bavarian Nordic Completes Enrollment in Global Phase 3 Trial of RSV Vaccine Candidate for Older Adults
December 22, 2022 06:00 ET | Bavarian Nordic A/S
20,000 adults aged 60 years and older have been enrolled according to planTop-line results are anticipated in mid-2023 COPENHAGEN, Denmark, December 22, 2022 – Bavarian Nordic A/S (OMX: BAVA)...
Bavarian Nordic fuldfører rekruttering til globalt fase 3-forsøg med RSV-vaccine til ældre personer
December 22, 2022 06:00 ET | Bavarian Nordic A/S
20.000 personer i alderen 60 år og opefter er rekrutteret som planlagtToplinjeresultater forventes i midten af 2023 KØBENHAVN, Danmark, 22. december 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
December 08, 2022 15:40 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
December 08, 2022 15:40 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 8. december 2022 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic
December 08, 2022 15:35 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to issue warrants to members of the Executive Management and selected...
Bavarian Nordic iværksætter nyt incitamentsprogram for koncernledelsen og udvalgte medarbejdere
December 08, 2022 15:35 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 8. december 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at bestyrelsen har besluttet at udstede tegningsoptioner til koncernledelsen og udvalgte medarbejdere i Bavarian...